期刊
MARINE DRUGS
卷 21, 期 1, 页码 -出版社
MDPI
DOI: 10.3390/md21010017
关键词
Schizochytrium sp; glucose-6-phosphate dehydrogenase; docosahexaenoic acid; NADPH; polyunsaturated fatty acid
This study demonstrated that overexpression of endogenous glucose-6-phosphate dehydrogenase (G6PD) gene in Schizochytrium sp. H016 increased the availability of NADPH, resulting in higher yield of docosahexaenoic acid (DHA) and lipid accumulation. These findings uncovered the beneficial effects of NADPH on PUFA synthesis in Schizochytrium sp. H016 and provided a promising regulatory strategy for large-scale DHA production.
Docosahexaenoic acid (DHA) is an important omega-3 polyunsaturated fatty acid (PUFA) that plays a critical physiological role in human health. Schizochytrium sp. is considered an excellent strain for DHA production, but the synthesis of DHA is limited by the availability of nicotinamide adenine dinucleotide phosphate (NADPH). In this study, the endogenous glucose-6-phosphate dehydrogenase (G6PD) gene was overexpressed in Schizochytrium sp. H016. Results demonstrated that G6PD overexpression increased the availability of NADPH, which ultimately altered the fatty acid profile, resulting in a 1.91-fold increase in DHA yield (8.81 g/L) and increased carbon flux by shifting it from carbohydrate and protein synthesis to lipid production. Thus, G6PD played a vital role in primary metabolism. In addition, G6PD significantly increased DHA content and lipid accumulation by 31.47% and 40.29%, respectively. The fed-batch fermentation experiment results showed that DHA production reached 17.01 g/L in the overexpressing G6PD strain. These results elucidated the beneficial effects of NADPH on the synthesis of PUFA in Schizochytrium sp. H016, which may be a potential target for metabolic engineering. Furthermore, this study provides a promising regulatory strategy for the large-scale production of DHA in Schizochytrium sp.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据